Home / Stocks / LRCX

Lam Research (LRCX, Semiconductor Materials & Equipment) Stock Valuation & Fair Value Significantly overvalued

Lam Research (LRCX, Semiconductor Materials & Equipment) trades at a blended P/E of 51.5, about 200% above its historical normal valuation, with a forward growth estimate of 29.3% and a PEG of 1.76. Analysts' one-year estimates have been hit 27% of the time. Priced at its historical normal P/E of 17.2 on the same blended earnings, the 2026-10-02 close of $347.49 corresponds to about $116 a share. This is a valuation reference, not a price target.

Blended P/E
51.5
Normal P/E
17.2
PEG
1.76
Fwd growth
29.3%
Div yield
0.4%
RSI (14)
51.9
Neutral
Technical context
  • Price $320.59 at the 2026-10-08 close, 3.5% above the 20-day average ($309.70) and 3.4% above the 50-day ($310.02).
  • RSI (14) at 51.9.
  • 52-week range $130.77 to $432.87: the price is 25.9% below the high and 145.2% above the low.
  • At its last earnings report the options market priced a 9.5% move.

The Street vs SeerForecast

Wall Street's mean price target for LRCX is $375.06 across 31 analysts, 17.0% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-06-03.

Blended P/E and rating by weekBlended P/E moved from 57.5 to 51.5 between 2026-06-03 and 2026-10-02, against a normal P/E of 17.2, with 6 rating changes over 37 recorded weeks.2026-06-03: P/E 57.5, Significantly overvalued, recalculated for the week of 2026-06-032026-06-10: P/E 54.5, Significantly overvalued, recalculated for the week of 2026-06-102026-06-12: P/E 54.5, Significantly overvalued, recalculated for the week of 2026-06-142026-06-16: P/E 54.5, Significantly overvalued, recalculated for the week of 2026-06-162026-06-18: P/E 54.5, Significantly overvalued, recalculated for the week of 2026-06-212026-07-02: P/E 68.8, Significantly overvalued, recalculated for the week of 2026-07-022026-07-06: P/E 61.8, Significantly overvalued, recalculated for the week of 2026-07-062026-07-09: P/E 61.8, Significantly overvalued, recalculated for the week of 2026-07-092026-07-10: P/E 61.0, Significantly overvalued, recalculated for the week of 2026-07-122026-07-13: P/E 61.0, Significantly overvalued, recalculated for the week of 2026-07-132026-07-14: P/E 61.0, Significantly overvalued, recalculated for the week of 2026-07-142026-07-20: P/E 54.1, Significantly overvalued, recalculated for the week of 2026-07-202026-07-22: P/E 54.1, Significantly overvalued, recalculated for the week of 2026-07-222026-07-24: P/E 52.3, Significantly overvalued, recalculated for the week of 2026-07-252026-07-27: P/E 52.3, Significantly overvalued, recalculated for the week of 2026-07-272026-07-31: P/E 48.8, Favorable on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 47.9, Favorable on our tests, recorded live 2026-08-032026-08-07: P/E 49.5, Significantly overvalued, recalculated for the week of 2026-08-072026-08-07: P/E 50.3, Significantly overvalued, recorded live 2026-08-102026-08-14: P/E 54.0, Significantly overvalued, recalculated for the week of 2026-08-142026-08-14: P/E 53.1, Significantly overvalued, recorded live 2026-08-172026-08-21: P/E 53.1, Significantly overvalued, recalculated for the week of 2026-08-212026-08-21: P/E 49.7, Significantly overvalued, recorded live 2026-08-242026-08-27: P/E 49.7, Significantly overvalued, recalculated for the week of 2026-08-272026-08-28: P/E 50.0, Significantly overvalued, recalculated for the week of 2026-08-282026-08-28: P/E 47.3, Favorable on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 47.3, Favorable on our tests, recorded live 2026-08-312026-09-04: P/E 47.7, Significantly overvalued, recalculated for the week of 2026-09-052026-09-04: P/E 47.7, Significantly overvalued, recorded live 2026-09-072026-09-11: P/E 45.7, Favorable on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 45.7, Favorable on our tests, recorded live 2026-09-142026-09-18: P/E 43.7, Favorable on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 43.7, Favorable on our tests, recorded live 2026-09-212026-09-25: P/E 47.2, Significantly overvalued, recalculated for the week of 2026-09-262026-09-25: P/E 47.2, Significantly overvalued, recorded live 2026-09-282026-10-02: P/E 51.5, Significantly overvalued, recalculated for the week of 2026-10-032026-10-02: P/E 51.5, Significantly overvalued, recorded live 2026-10-0520.040.060.0Jun 3Jul 3Aug 2Sep 2Oct 2Normal P/E 17.2
Favorable on our testsSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 57.5+260%Significantly overvalued (recalculated)
2026-07-02P/E 68.8+331%Significantly overvalued (recalculated)
2026-07-31P/E 48.8+184%Favorable on our tests (recalculated)
2026-08-07P/E 49.5+189%Significantly overvalued (recalculated)
2026-08-30P/E 47.3+175%Favorable on our tests (recalculated)
2026-09-05P/E 47.7+178%Significantly overvalued (recalculated)
2026-09-12P/E 45.7+166%Favorable on our tests (recalculated)
2026-09-19P/E 43.7+155%Favorable on our tests (recalculated)
2026-09-26P/E 47.2+175%Significantly overvalued (recalculated)
2026-10-05P/E 51.5+200%Significantly overvalued ← now
Show all 37 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 57.5+260%Significantly overvalued (recalculated)
2026-06-10P/E 54.5+242%Significantly overvalued (recalculated)
2026-06-14P/E 54.5+242%Significantly overvalued (recalculated)
2026-06-16P/E 54.5+242%Significantly overvalued (recalculated)
2026-06-21P/E 54.5+242%Significantly overvalued (recalculated)
2026-07-02P/E 68.8+331%Significantly overvalued (recalculated)
2026-07-06P/E 61.8+287%Significantly overvalued (recalculated)
2026-07-09P/E 61.8+287%Significantly overvalued (recalculated)
2026-07-12P/E 61.0+282%Significantly overvalued (recalculated)
2026-07-13P/E 61.0+282%Significantly overvalued (recalculated)
2026-07-14P/E 61.0+282%Significantly overvalued (recalculated)
2026-07-20P/E 54.1+239%Significantly overvalued (recalculated)
2026-07-22P/E 54.1+239%Significantly overvalued (recalculated)
2026-07-25P/E 52.3+227%Significantly overvalued (recalculated)
2026-07-27P/E 52.3+227%Significantly overvalued (recalculated)
2026-07-31P/E 48.8+184%Favorable on our tests (recalculated)
2026-08-03P/E 47.9+179%Favorable on our tests
2026-08-07P/E 49.5+189%Significantly overvalued (recalculated)
2026-08-10P/E 50.3+193%Significantly overvalued
2026-08-14P/E 54.0+215%Significantly overvalued (recalculated)
2026-08-17P/E 53.1+210%Significantly overvalued
2026-08-21P/E 53.1+210%Significantly overvalued (recalculated)
2026-08-24P/E 49.7+190%Significantly overvalued
2026-08-27P/E 49.7+190%Significantly overvalued (recalculated)
2026-08-28P/E 50.0+191%Significantly overvalued (recalculated)
2026-08-30P/E 47.3+175%Favorable on our tests (recalculated)
2026-08-31P/E 47.3+175%Favorable on our tests
2026-09-05P/E 47.7+178%Significantly overvalued (recalculated)
2026-09-07P/E 47.7+178%Significantly overvalued
2026-09-12P/E 45.7+166%Favorable on our tests (recalculated)
2026-09-14P/E 45.7+166%Favorable on our tests
2026-09-19P/E 43.7+155%Favorable on our tests (recalculated)
2026-09-21P/E 43.7+155%Favorable on our tests
2026-09-26P/E 47.2+175%Significantly overvalued (recalculated)
2026-09-28P/E 47.2+175%Significantly overvalued
2026-10-03P/E 51.5+200%Significantly overvalued (recalculated)
2026-10-05P/E 51.5+200%Significantly overvalued ← now

Earnings moves: LRCX moved more than the options market implied in 1 of 1 recent tracked reports.

Frequently asked questions

Is Lam Research stock overvalued?

At a blended P/E of 51.5 versus its historical normal P/E of 17.2, Lam Research trades about 200% above its typical valuation, with a PEG of 1.76 on 29.3% forward growth. tickerseer currently rates it significantly overvalued.

What is Lam Research's fair value and PEG?

Lam Research trades at a blended P/E of 51.5 against a historical normal P/E of 17.2, a PEG of 1.76, and a forward growth estimate of 29.3%. Priced at its historical normal P/E of 17.2 on the same blended earnings, the 2026-10-02 close of $347.49 corresponds to about $116 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Lam Research changed?

tickerseer's rating has been significantly overvalued since 2026-06-03.

What is the analyst price target for Lam Research?

The mean Wall Street price target for Lam Research is $375.06 across 31 analysts, 17.0% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Semiconductor Materials & Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.